Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05614791

Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience

Conditions: Measles

Sex: All
Ages: 1 Month – 18 Years
Enrollment: 40
Sponsor: Marmara University

Location: Turkey

Summary

Measles, can be prevented and eliminated by vaccination, is a highly contagious viral disease that can lead to serious complications, disability, and death. As a result of the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) strategic plans, the annual global incidence of measles decreased by 75% over the period 2000-2015, and the estimated global mortality rate fell by 73%. For the current 2019 period, the European and the Eastern Mediterranean Region has recorded respectively more than two-fold and 1.5-fold increase in reported measles cases. As it is known, no specific antiviral treatment exists for the measles virus therefore, vaccination is still the most effective method of preventing disease.The aim of this study was to evaluate the measles cases in districts where the refugees live quite intensely.

Eligibility Criteria

Inclusion Criteria:The suspicious case of measlesMeasles/Rubella Case Notification and Laboratory request and result form and Measles/ Rubella Case Study form must be filledAccept the informed consent formPositive Measles Ig M and Measles Ig G laboratory testExclusion Criteria:Rejected the informed consent form

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05614791). StuddyBuddy aggregates publicly available trial information.